Annual CFI
$11.78 M
+$19.05 M+262.19%
01 June 2022
Summary:
Pluristem Therapeutics annual cash flow from investing activities is currently $11.78 million, with the most recent change of +$19.05 million (+262.19%) on 01 June 2022. During the last 3 years, it has risen by +$19.05 million (+262.19%).PSTI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$6.39 M
+$9.35 M+316.35%
01 September 2022
Summary:
Pluristem Therapeutics quarterly cash flow from investing activities is currently $6.39 million, with the most recent change of +$9.35 million (+316.35%) on 01 September 2022.PSTI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$25.42 M
+$13.63 M+115.70%
01 September 2022
Summary:
Pluristem Therapeutics TTM cash flow from investing activities is currently $25.42 million, with the most recent change of +$13.63 million (+115.70%) on 01 September 2022.PSTI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +262.2% | +188.3% | +235.9% |
| 5 y5 years | +907.1% | +34.6% | +1589.8% |
PSTI Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -45.3% | -55.3% | at high |
Pluristem Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $6.39 M(-316.3%) | $25.42 M(+115.7%) |
| June 2022 | $11.78 M(-262.2%) | -$2.96 M(-138.6%) | $11.78 M(-39.7%) |
| Mar 2022 | - | $7.66 M(-46.5%) | $19.53 M(-263.3%) |
| Dec 2021 | - | $14.31 M(-297.7%) | -$11.96 M(-36.1%) |
| Sept 2021 | - | -$7.24 M(-251.1%) | -$18.70 M(+157.5%) |
| June 2021 | -$7.26 M(-76.1%) | $4.79 M(-120.1%) | -$7.26 M(-86.5%) |
| Mar 2021 | - | -$23.83 M(-414.7%) | -$53.85 M(+83.5%) |
| Dec 2020 | - | $7.57 M(+80.3%) | -$29.35 M(-5.4%) |
| Sept 2020 | - | $4.20 M(-110.0%) | -$31.01 M(+1.8%) |
| June 2020 | -$30.46 M(-2703.2%) | -$41.79 M(-6300.6%) | -$30.46 M(+324.1%) |
| Mar 2020 | - | $674.00 K(-88.6%) | -$7.18 M(+564.9%) |
| Dec 2019 | - | $5.91 M(+24.5%) | -$1.08 M(-36.7%) |
| Sept 2019 | - | $4.75 M(-125.6%) | -$1.71 M(-245.8%) |
| June 2019 | $1.17 M(-79.4%) | -$18.52 M(-373.3%) | $1.17 M(-95.4%) |
| Mar 2019 | - | $6.78 M(+28.2%) | $25.16 M(+22.0%) |
| Dec 2018 | - | $5.29 M(-30.7%) | $20.62 M(+1240.5%) |
| Sept 2018 | - | $7.62 M(+39.2%) | $1.54 M(-72.9%) |
| June 2018 | $5.68 M(+30.4%) | $5.48 M(+145.6%) | $5.68 M(-4.8%) |
| Mar 2018 | - | $2.23 M(-116.2%) | $5.97 M(-170.4%) |
| Dec 2017 | - | -$13.79 M(-217.2%) | -$8.48 M(-168.8%) |
| Sept 2017 | - | $11.77 M(+104.1%) | $12.33 M(+183.1%) |
| June 2017 | $4.36 M(+231.9%) | $5.77 M(-147.2%) | $4.36 M(-12.1%) |
| Mar 2017 | - | -$12.22 M(-274.2%) | $4.95 M(-78.7%) |
| Dec 2016 | - | $7.01 M(+84.8%) | $23.21 M(+66.2%) |
| Sept 2016 | - | $3.79 M(-40.4%) | $13.96 M(+964.4%) |
| June 2016 | $1.31 M(-93.9%) | $6.36 M(+5.3%) | $1.31 M(-160.0%) |
| Mar 2016 | - | $6.04 M(-370.3%) | -$2.19 M(+687.1%) |
| Dec 2015 | - | -$2.24 M(-74.8%) | -$278.00 K(-103.4%) |
| Sept 2015 | - | -$8.86 M(-409.4%) | $8.16 M(-62.1%) |
| June 2015 | $21.54 M(+986.1%) | $2.86 M(-64.0%) | $21.54 M(-11.3%) |
| Mar 2015 | - | $7.95 M(+28.2%) | $24.28 M(+139.1%) |
| Dec 2014 | - | $6.20 M(+37.4%) | $10.16 M(+338.3%) |
| Sept 2014 | - | $4.52 M(-19.5%) | $2.32 M(+16.8%) |
| June 2014 | $1.98 M(-110.0%) | $5.61 M(-190.9%) | $1.98 M(-111.2%) |
| Mar 2014 | - | -$6.17 M(+277.4%) | -$17.76 M(+653.6%) |
| Dec 2013 | - | -$1.64 M(-139.1%) | -$2.36 M(-81.9%) |
| Sept 2013 | - | $4.18 M(-129.6%) | -$13.01 M(-34.3%) |
| June 2013 | -$19.80 M(-35.7%) | -$14.14 M(-253.1%) | -$19.80 M(+175.7%) |
| Mar 2013 | - | $9.23 M(-175.2%) | -$7.18 M(-19.9%) |
| Dec 2012 | - | -$12.29 M(+370.7%) | -$8.96 M(+1998.6%) |
| Sept 2012 | - | -$2.61 M(+71.6%) | -$427.00 K(-98.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | -$30.80 M(>+9900.0%) | -$1.52 M(-120.4%) | -$30.80 M(+4.2%) |
| Mar 2012 | - | $7.46 M(-298.7%) | -$29.57 M(-20.4%) |
| Dec 2011 | - | -$3.75 M(-88.6%) | -$37.13 M(+12.5%) |
| Sept 2011 | - | -$32.98 M(>+9900.0%) | -$33.02 M(>+9900.0%) |
| June 2011 | -$36.00 K(-97.2%) | -$291.00 K(+159.8%) | -$36.00 K(-185.7%) |
| Mar 2011 | - | -$112.00 K(-130.9%) | $42.00 K(-97.5%) |
| Dec 2010 | - | $363.00 K(+8975.0%) | $1.70 M(-237.1%) |
| Sept 2010 | - | $4000.00(-101.9%) | -$1.24 M(-4.2%) |
| June 2010 | -$1.30 M(-256.1%) | -$213.00 K(-113.8%) | -$1.30 M(+52.5%) |
| Mar 2010 | - | $1.55 M(-160.0%) | -$850.00 K(-68.9%) |
| Dec 2009 | - | -$2.58 M(+4958.8%) | -$2.74 M(+1472.4%) |
| Sept 2009 | - | -$51.00 K(-121.9%) | -$174.00 K(-121.0%) |
| June 2009 | $830.00 K(-35.4%) | $233.00 K(-168.9%) | $830.00 K(+5.6%) |
| Mar 2009 | - | -$338.00 K(+1777.8%) | $786.00 K(-70.8%) |
| Dec 2008 | - | -$18.00 K(-101.9%) | $2.69 M(+12.1%) |
| Sept 2008 | - | $953.00 K(+404.2%) | $2.40 M(+87.1%) |
| June 2008 | $1.28 M(-121.0%) | $189.00 K(-88.0%) | $1.28 M(-126.8%) |
| Mar 2008 | - | $1.57 M(-609.7%) | -$4.80 M(-26.1%) |
| Dec 2007 | - | -$308.00 K(+85.5%) | -$6.49 M(+3.5%) |
| Sept 2007 | - | -$166.00 K(-97.2%) | -$6.27 M(+2.3%) |
| June 2007 | -$6.13 M(>+9900.0%) | -$5.89 M(+4730.2%) | -$6.13 M(+2342.0%) |
| Mar 2007 | - | -$122.00 K(+35.6%) | -$251.10 K(+83.8%) |
| Dec 2006 | - | -$90.00 K(+233.3%) | -$136.60 K(+145.7%) |
| Sept 2006 | - | -$27.00 K(+123.1%) | -$55.60 K(+7.5%) |
| June 2006 | -$51.80 K(+13.6%) | -$12.10 K(+61.3%) | -$51.70 K(-9.6%) |
| Mar 2006 | - | -$7500.00(-16.7%) | -$57.20 K(+19.2%) |
| Dec 2005 | - | -$9000.00(-61.0%) | -$48.00 K(-27.7%) |
| Sept 2005 | - | -$23.10 K(+31.3%) | -$66.40 K(+45.6%) |
| June 2005 | -$45.60 K(-64.0%) | -$17.60 K(-1135.3%) | -$45.60 K(-1.5%) |
| Mar 2005 | - | $1700.00(-106.2%) | -$46.30 K(-65.6%) |
| Dec 2004 | - | -$27.40 K(+1091.3%) | -$134.70 K(+12.7%) |
| Sept 2004 | - | -$2300.00(-87.4%) | -$119.50 K(-5.8%) |
| June 2004 | -$126.80 K(+141.5%) | -$18.30 K(-78.9%) | -$126.90 K(-21.2%) |
| Mar 2004 | - | -$86.70 K(+610.7%) | -$161.10 K(+116.5%) |
| Dec 2003 | - | -$12.20 K(+25.8%) | -$74.40 K(+19.6%) |
| Sept 2003 | - | -$9700.00(-81.5%) | -$62.20 K(+18.5%) |
| June 2003 | -$52.50 K(+236.5%) | -$52.50 K(<-9900.0%) | -$52.50 K(+236.5%) |
| Mar 2003 | - | $0.00(0.0%) | -$15.60 K(0.0%) |
| Dec 2002 | - | $0.00(0.0%) | -$15.60 K(-100.2%) |
| Sept 2002 | - | $0.00(-100.0%) | $6.57 M(0.0%) |
| June 2002 | -$15.60 K | -$15.60 K(-100.2%) | $6.57 M(-0.2%) |
| Dec 2001 | - | $6.59 M | $6.59 M |
FAQ
- What is Pluristem Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Pluristem Therapeutics?
- What is Pluristem Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Pluristem Therapeutics?
What is Pluristem Therapeutics annual cash flow from investing activities?
The current annual CFI of PSTI is $11.78 M
What is the all time high annual CFI for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual cash flow from investing activities is $21.54 M
What is Pluristem Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PSTI is $6.39 M
What is the all time high quarterly CFI for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly cash flow from investing activities is $14.31 M
What is Pluristem Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PSTI is $25.42 M
What is the all time high TTM CFI for Pluristem Therapeutics?
Pluristem Therapeutics all-time high TTM cash flow from investing activities is $25.42 M